Rationale and design of a prospective, multicentre, stop tyrosine kinase inhibitor trial of paediatric patients with chronic myeloid Leukaemia with sustained complete molecular response (STKI-14)

Akiko Kada, Haruko Shima, Chikako Tono, Yuki Yuza, Hidemitsu Kurosawa, Akihiro Watanabe, Masaki Ito, Hideko Uryu, Kiyoko Kamibeppu, Nobutaka Kiyokawa, Souichi Adachi, Akiko M. Saito, Akihiko Tanizawa, Hiroyuki Shimada